Master Generative AI in Drug Discovery: From Molecular Design to Clinical Validation in 4 weeks through hands-on, project-based online training with DSTC.
This 3-day course on Generative AI in Drug Discovery explores how cutting-edge AI models are reshaping pharmaceutical research, from molecular design to clinical validation. Participants will learn the fundamentals of generative AI, including GANs and VAEs, and their application in predicting molecular properties, designing drug-like compounds, and optimizing leads. Every participant receives a verified e-Certificate and e-Marksheet from the Deep Science & Technology Consortium.
This 3-day course on Generative AI in Drug Discovery explores how cutting-edge AI models are reshaping pharmaceutical research, from molecular design to clinical validation. Participants will learn the fundamentals of generative AI, including GANs and VAEs, and their application in predicting molecular properties, designing drug-like compounds, and optimizing leads.
1. Translate biotechnology theory into practical, reproducible analysis.
2. Build a defensible project you can showcase to supervisors, reviewers, or employers.
β’ Master's and senior undergraduate students specializing in biotechnology
β’ R&D engineers and working professionals applying biotechnology in industry
β’ Academics and educators building research or teaching capacity in biotechnology
β’ Tangible, reproducible biotechnology work to show supervisors or employers.
β’ A verified e-Certificate of competency and e-Marksheet from the Deep Science & Technology Consortium.
Understand the core concepts and importance of Generative AI in scientific research. β’ Differentiate between traditional and AI-driven drug discovery pipelines. β’ Explore key applications of AI in molecular design and lead optimization.
Learn the principles of Generative Adversarial Networks (GANs) and Variational Autoencoders (VAEs). β’ Apply GANs and VAEs for de novo molecular design and generation. β’ Conduct hands-on exercises using DeepChem/RDKit to generate novel molecules.
Utilize AI models for accurate prediction of ADMET properties, solubility, and toxicity. β’ Evaluate molecular binding affinity using advanced AI techniques. β’ Perform practical property prediction with RDKit/DeepChem.
Employ AI for efficient large-scale virtual screening of compound libraries. β’ Discover new therapeutic uses for existing drugs through AI-driven repurposing strategies. β’ Implement AI tools to screen molecules for bioactivity.
Leverage AI for toxicity assessment and efficacy prediction in preclinical studies. β’ Identify and validate biomarkers using AI for enhanced clinical understanding. β’ Predict clinical trial success rates through robust AI models.
Analyze the current challenges and future opportunities in applying AI to drug discovery. β’ Discuss the ethical considerations and responsible implementation of AI in pharmaceuticals. β’ Formulate strategies for integrating AI into real-world drug development pipelines.
| Parameter | Requirement |
|---|---|
| Covered Tool / Platform | RDKit |
| Covered Tool / Platform | DeepChem |
| Covered Tool / Platform | GANs |
| Covered Tool / Platform | VAEs |
Based on 0 scholar submissions
No verified reviews published yet. Be the first to share your academic experience.
Your rating will help prospective scholars. Ratings below 3 stars are routed privately to the faculty mentor for immediate response.